Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > Ameridose Pulls Back All Products; Recall Tied to NECC

Drug Industry Daily

Nov. 1, 2012 | Vol. 11 No. 215

Ameridose Pulls Back All Products; Recall Tied to NECC

Ameridose is recalling all of its unexpired product as an ongoing FDA inspection of its Westborough, Mass., facility has raised sterility concerns.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Related Articles

FDA Issues Safety Alerts on Botox, Hospira and Potiga FDA Issues Safety Alerts on Anti-Seizure Drug, Bogus Botox and Hospira Teva Recalls Multiple Lots of Off-Color Birth Control Pills Teva Recalls Multiple Lots of Off-Color Birth Control Pills

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.